• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谁来监管监管者?关于HDAC9的二十年研究

Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9.

作者信息

Brancolini Claudio, Di Giorgio Eros, Formisano Luigi, Gagliano Teresa

机构信息

Department of Medicine, Università degli Studi di Udine, p.le Kolbe 4, 33100 Udine, Italy.

Department of Neuroscience, School of Medicine, "Federico II" University of Naples, Via Pansini, 5, 80131 Naples, Italy.

出版信息

Life (Basel). 2021 Jan 27;11(2):90. doi: 10.3390/life11020090.

DOI:10.3390/life11020090
PMID:33513699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7912504/
Abstract

Understanding how an epigenetic regulator drives different cellular responses can be a tricky task. Very often, their activities are modulated by large multiprotein complexes, the composition of which is context- and time-dependent. As a consequence, experiments aimed to unveil the functions of an epigenetic regulator can provide different outcomes and conclusions, depending on the circumstances. HDAC9 (histone deacetylase), an epigenetic regulator that influences different differentiating and adaptive responses, makes no exception. Since its discovery, different phenotypes and/or dysfunctions have been observed after the artificial manipulation of its expression. The cells and the microenvironment use multiple strategies to control and monitor HDAC9 activities. To date, some of the genes under HDAC9 control have been identified. However, the exact mechanisms through which HDAC9 can achieve all the different tasks so far described, remain mysterious. Whether it can assemble into different multiprotein complexes and how the cells modulate these complexes is not clearly defined. In summary, despite several cellular responses are known to be affected by HDAC9, many aspects of its network of interactions still remain to be defined.

摘要

理解一种表观遗传调节因子如何驱动不同的细胞反应可能是一项棘手的任务。通常,它们的活性由大型多蛋白复合物调节,而这些复合物的组成取决于环境和时间。因此,旨在揭示表观遗传调节因子功能的实验可能会根据情况提供不同的结果和结论。HDAC9(组蛋白去乙酰化酶)作为一种影响不同分化和适应性反应的表观遗传调节因子,也不例外。自其被发现以来,在人工操纵其表达后观察到了不同的表型和/或功能障碍。细胞和微环境使用多种策略来控制和监测HDAC9的活性。到目前为止,已经确定了一些受HDAC9控制的基因。然而,HDAC9实现迄今为止所描述的所有不同任务的确切机制仍然是个谜。它是否能组装成不同的多蛋白复合物以及细胞如何调节这些复合物尚不清楚。总之,尽管已知几种细胞反应受HDAC9影响,但其相互作用网络的许多方面仍有待确定。

相似文献

1
Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9.谁来监管监管者?关于HDAC9的二十年研究
Life (Basel). 2021 Jan 27;11(2):90. doi: 10.3390/life11020090.
2
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.不同的 IIa 类 HDAC 抑制复合物调节与平滑肌肉瘤细胞存活相关的特定表观遗传反应。
Nucleic Acids Res. 2020 Jan 24;48(2):646-664. doi: 10.1093/nar/gkz1120.
3
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.转录激活因子和转录抑制因子MEF2复合物的共存影响肿瘤侵袭性。
PLoS Genet. 2017 Apr 18;13(4):e1006752. doi: 10.1371/journal.pgen.1006752. eCollection 2017 Apr.
4
Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.IIb类组蛋白去乙酰化酶6(HDAC6)与IIa类HDAC9的新型相互作用控制促性腺激素释放激素(GnRH)神经元细胞的存活和移动。
J Biol Chem. 2015 May 29;290(22):14045-56. doi: 10.1074/jbc.M115.640482. Epub 2015 Apr 14.
5
Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.HDAC9的过表达促进口腔鳞状细胞癌生长,调节细胞周期进程,并抑制细胞凋亡。
Mol Cell Biochem. 2016 Apr;415(1-2):183-96. doi: 10.1007/s11010-016-2690-5. Epub 2016 Mar 18.
6
Identifying targets for the restoration and reactivation of BRM.确定 BRM 的恢复和重新激活的靶标。
Oncogene. 2014 Jan 30;33(5):653-64. doi: 10.1038/onc.2012.613. Epub 2013 Mar 25.
7
Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.组蛋白去乙酰化酶9调节乳腺癌细胞增殖及对组蛋白去乙酰化酶抑制剂的反应。
Oncotarget. 2016 Apr 12;7(15):19693-708. doi: 10.18632/oncotarget.7564.
8
Regulation of class IIa HDAC activities: it is not only matter of subcellular localization.调控 IIa 类组蛋白去乙酰化酶的活性:这不仅仅关乎亚细胞定位。
Epigenomics. 2016 Feb;8(2):251-69. doi: 10.2217/epi.15.106. Epub 2016 Jan 21.
9
Quis custodiet ipsos custodes?谁来监督这些监督者?
Perspect Biol Med. 1977;20(2):246-59. doi: 10.1353/pbm.1977.0086.
10
Quis custodiet ipsos custodes.谁来监督这些监督者?
Nature. 1995 Nov 30;378(6556):432. doi: 10.1038/378432b0.

引用本文的文献

1
Class IIa HDACs Are Important Signal Transducers with Unclear Enzymatic Activities.IIa类组蛋白去乙酰化酶是具有不明酶活性的重要信号转导分子。
Biomolecules. 2025 Jul 22;15(8):1061. doi: 10.3390/biom15081061.
2
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.组蛋白去乙酰化酶驱动的抗癌耐药机制:表观遗传学及其他。
Cancer Drug Resist. 2024 Nov 20;7:46. doi: 10.20517/cdr.2024.103. eCollection 2024.
3
Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis.组蛋白去乙酰化酶:特发性肺纤维化的潜在治疗靶点。

本文引用的文献

1
A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.一种新型长链非编码RNA,即LOC440173,通过调节miR-30d-5p/HDAC9轴和上皮-间质转化来促进食管鳞状细胞癌的进展。
Mol Carcinog. 2020 Dec;59(12):1392-1408. doi: 10.1002/mc.23264. Epub 2020 Oct 20.
2
The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.调控性 T 细胞的下一个前沿:用于自身免疫性疾病和器官移植的有前景的免疫疗法。
Front Immunol. 2020 Sep 23;11:565518. doi: 10.3389/fimmu.2020.565518. eCollection 2020.
3
Front Cell Dev Biol. 2024 Aug 13;12:1426508. doi: 10.3389/fcell.2024.1426508. eCollection 2024.
4
Transgenic Overexpression of HDAC9 Promotes Adipocyte Hypertrophy, Insulin Resistance and Hepatic Steatosis in Aging Mice.HDAC9基因的转基因过表达促进衰老小鼠的脂肪细胞肥大、胰岛素抵抗和肝脂肪变性。
Biomolecules. 2024 Apr 18;14(4):494. doi: 10.3390/biom14040494.
5
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology.锌依赖的组蛋白去乙酰化酶在肺血管内皮病理生物学中的作用
Biomolecules. 2024 Jan 23;14(2):140. doi: 10.3390/biom14020140.
6
Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from as Histone Deacetylase 9 (HDAC9) Inhibitors.基于指纹图谱和数据挖掘技术探索作为组蛋白去乙酰化酶9(HDAC9)抑制剂的某些生物活性化合物。
Curr Comput Aided Drug Des. 2025;21(3):270-284. doi: 10.2174/0115734099282303240126061624.
7
Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels.缺氧诱导因子活性调控中的乙酰化和磷酸化:调节对氧水平变化适应的其他选择。
Life (Basel). 2023 Dec 21;14(1):20. doi: 10.3390/life14010020.
8
HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors.HDAC9 作为一个特权靶点:综述其在不同疾病中的作用及其抑制剂的构效关系(SARs)。
Mini Rev Med Chem. 2024;24(7):767-784. doi: 10.2174/0113895575267301230919165827.
9
Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death.通过诱导 HDAC9 依赖性的 HIF-1 和 Sp1 的去乙酰化,促进 TfR1 转录和 GPX4 的减少,从而决定了铁死亡性神经元死亡。
Int J Biol Sci. 2023 May 11;19(9):2695-2710. doi: 10.7150/ijbs.80735. eCollection 2023.
10
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications.癌症中的组蛋白去乙酰化酶4:一个不仅驱动表观遗传修饰的多任务平台。
Front Mol Biosci. 2023 Jan 24;10:1116660. doi: 10.3389/fmolb.2023.1116660. eCollection 2023.
Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer.
通过全基因组整合筛选鉴定出截短的 HDAC9,是三阴性乳腺癌中紫杉醇耐药的关键调节因子。
Theranostics. 2020 Sep 2;10(24):11092-11109. doi: 10.7150/thno.44997. eCollection 2020.
4
HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth.HDAC9在去分化的肝癌细胞中优先表达,并参与非锚定依赖性生长。
Cancers (Basel). 2020 Sep 23;12(10):2734. doi: 10.3390/cancers12102734.
5
Interactive Effects of a Combination of the HDAC3 and HDAC9 Genes with Diabetes Mellitus on the Risk of Ischemic Stroke.HDAC3 和 HDAC9 基因与糖尿病联合作用对缺血性脑卒中风险的交互影响。
Thromb Haemost. 2021 Mar;121(3):396-404. doi: 10.1055/s-0040-1717116. Epub 2020 Sep 22.
6
MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.MEF2D 在移植存活和抗肿瘤免疫过程中维持效应性 Foxp3+ Treg 的激活。
J Clin Invest. 2020 Dec 1;130(12):6242-6260. doi: 10.1172/JCI135486.
7
HDAC9 deficiency promotes tumor progression by decreasing the CD8 dendritic cell infiltration of the tumor microenvironment.HDAC9 缺失通过减少肿瘤微环境中 CD8 树突状细胞的浸润来促进肿瘤进展。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000529.
8
Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.组蛋白去乙酰化酶 9 通过激活 IKK 调节动脉粥样硬化斑块易损性。
Circ Res. 2020 Aug 28;127(6):811-823. doi: 10.1161/CIRCRESAHA.120.316743. Epub 2020 Jun 17.
9
Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.环磷酸腺苷通过组蛋白去乙酰化酶5的心肌细胞特异性低磷酸化来抑制病理性的肌细胞增强因子2激活。
J Mol Cell Cardiol. 2020 Aug;145:88-98. doi: 10.1016/j.yjmcc.2020.05.018. Epub 2020 May 30.
10
Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effect.组蛋白去乙酰化酶 9 启动子低甲基化与脂肪细胞功能障碍有关,是他汀类药物相关的代谢效应。
Clin Epigenetics. 2020 May 14;12(1):68. doi: 10.1186/s13148-020-00858-w.